IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Neurology in New Jersey

In 2025 Q1–Q4, the provider or facility offer prevailed in 84.5% of 3,406 determined Federal IDR dispute line items for neurology in New Jersey. The median prevailing offer was 43.92x the QPA (25th–75th percentile 16.15x–71.48x; n = 3,244). The median time to a decision was 36 business days (n = 3,406).

Determined line items

3,406

2025 Q1–Q4 · 6 split decisions excluded

Provider win rate

84.5%

n = 3,406 · 2025 Q1–Q4

Median payment vs QPA

43.92x †

middle half 16.15x–71.48x · n = 3,244 · 2025 Q1–Q4

Median days to decision

36

business days, from dispute initiation · n = 3,406 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q43,40684.5%43.92x †16.15x–71.48x3,24436
2024 Q1–Q42,06383.1%24.53x †4.27x–55.32x2,01560
2023 Q1–Q412348.0%6.80x1.00x–18.40x12195
2023 Q1–2025 Q45,59283.2%36.49x †7.17x–65.88x5,380not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
95720 Measurement of brain wave activity with video (VEEG), 12-26 hours with review an52990.7%52.47x †48634
95941 Continuous remote monitoring of nervous system during operation, each hour33381.1%14.77x32062
95939 Placement of skin electrodes and measurement of central motor stimulation in arm32380.2%52.64x †31234
95938 Placement of skin electrodes and measurement of stimulated sites on arms and leg31977.1%88.01x †30740
95718 Measurement of brain wave activity with video (VEEG), 2-12 hours with review and23393.1%60.39x †23134
99232 Subsequent hospital care with moderate levelof medical decision making, if using22688.1%53.26x †22627
95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities15370.6%33.12x †13543
99233 Subsequent hospital care with moderate levelof medical decision making, if using11991.6%37.38x †11933
95937 Testing of nerve-muscle junction11571.3%67.92x †11036
99222 Initial hospital care with straightforward or low-level medical decision making,10091.0%27.57x †10029
99291 Critical care, first 30-74 minutes8196.3%30.96x †7535
99223 Initial hospital care with moderate level of medical decision making, if using t6088.3%15.48x6038
95886 Needle measurement of electrical activity in arm or leg muscles, complete study4682.6%98.94x †4626.5

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in New Jersey · Neurology in all states

FAQ

What is the Federal IDR provider win rate for neurology in New Jersey?

In 2025 Q1–Q4, the provider or facility offer was selected in 84.5% of 3,406 determined dispute line items for neurology in New Jersey. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for neurology in New Jersey?

In 2025 Q1–Q4, the median prevailing offer was 43.92x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 16.15x to 71.48x (n = 3,244 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for neurology in New Jersey?

In 2025 Q1–Q4, the median was 36 business days (n = 3,406 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR